Meet the Expert
MTE 1
Plenary Session
Session 1 – GDMT Essentials in the Real Life Setting
Chairs – Vijay Chopra and Camilla Hage
-
The 4 Pillars of GDMT Sequencing and Titration – Gianluigi Savarese
-
Managing GDMT and Hypotension – Michael Böhm
-
Implementing GDMT in the Frail and Elderly Patient – Cristiana Vitale
-
How to Manage GDMT in Advanced HF
-
Panel Discussion
Meet the Expert
MTE 2
Plenary Session
Session 2 – Updates on Recent Trials in HF
Chair – Stefan Anker
-
The VICTOR Trial – Faiez Zannad
-
FAIR-HF2
-
DIGIT-HF – Udo Bavendiek
-
MAPLE-HCM
-
Panel Discussion
Symposium
Symposium 1
Plenary Session
Session 3 – Obesity and Weight Management in HF
Chair – Anu Lala-Trindade
Obesity and HF: Epidemiology and Mechanisms
Overview of Current Therapeutic Agents and Their Trial Results
New GLP1-based Drugs in the Pipeline – Dimitris Papamargaritis
Weight Loss Therapies and Body Composition Changes – Stefan Anker
Panel Discussion
Meet the Expert
MTE 3
Plenary Session
Session 4 – Managing Cardiomyopathy in HF
Chair – Pedro Schwartzmann
Cardiomyopathies and HF: What Should the Clinician Know Features
Differential Diagnosis – Rodney Falk
Management of Cardiac Amyloidosis – Marianna Fontana
New Approaches in the Management of HCM – Ahmad Masri
Panel Discussion
Meet the Expert
MTE 4
Plenary Session
Session 5 – Cardiac Rhythm in HF
Chair – William Abraham
CRM Devices: Cornerstones of Patient-centred Management in HF – Biykem Bozkurt
Prevention of Sudden Arrythmic Death in HFrEF – Carsten Israel
CRT in HFrEF for Whom and When
Managing the Temporary High Risk of SCD
Panel Discussion
Plenary Session
Session 6 – Devices in HF: Time to Reassess Their Place?
Chair – Pedro Schwartzmann
-
Neuromodulation Therapy for HFrEF – JoAnn Lindenfeld
-
CCM: Benefits of Early Implementation – Marat Fudim
-
Interatrial Shunts
-
Sleep Apnoea – William Abraham
-
Panel Discussion
Plenary Session
Session 7 – Managing HFpEF in 2025
Chair – Oliver Schnell
-
Diagnosis of HFpEF and Management Principles: The Basics – Cristina Gavina
-
Pillar 1 of HFpEF Therapy: SGLT2-inhibitor – Kieran Docherty
-
Pillar 2 of HFpEF Therapy: MRAs – Gerasimos Filippatos
-
The Experience in Primary Care – Ana Maria Cebrián Cuenca
-
Panel Discussion
Plenary Session
Session 8 – Enabling GDMT in HF
Chairs – David Sim and Ewa Jankowska
-
The Role of Potassium Binders – Francesca Musella
-
The Role of SGLT2i in Preventing Hyperkalemia
-
Devices to Enable Drug Therapy
-
Lessons Learned From REVOLUTION HF – Lisa Anderson
-
Panel Discussion
Meet the Expert
MTE 5
Plenary Session
Session 9 – Improving Heart and Kidney Outcomes: The Role of MRAs
Chairs – Clara Inés Saldarriaga and Shelley Zieroth
-
Improving Outcomes for the Heart and Kidney – Biykem Bozkurt
-
The Role of Steroidal MRAs in HF – Joao Ferreira
-
Clinical Implications of the FINEARTS-HF
-
The Future of Heart and Kidney Therapies – Scott Solomon
-
Panel Discussion
Meet the Expert
MTE 6
Plenary Session
Session 10 – Valvular Heart Disease
Management of FMR in HF
Management of TR in HF
TAVI in HF Patients
Renal Denervation Therapy
Panel Discussion
Meet the Expert
MTE 7
Plenary Session
Session 11 – Remote Monitoring and Team Approaches in the Management of HF
Chair – JoAnn Lindenfeld
-
Latest Experience with Haemodynamic Monitoring – JoAnn Lindenfeld
-
New Device: From Voice Recognition to Lung Water Assessment – William Abraham
-
Reducing HF Hospitalisation by Disease Management Programme
-
Evaluation and Treatment of HF With Linq Sensors – Javed Butler
-
Panel Discussion
Replay
William Abraham
The Ohio State University, Columbus, US
Lisa Anderson
St George’s Hospital, London, UK
Stefan Anker
Charité Campus Virchow-Klinikum, Berlin, DE
Udo Bavendiek
Hannover Medical School, Hannover, DE
Michael Böhm
Saarland University Hospital, Homburg, DE
Biykem Bozkurt
Baylor College of Medicine, Texas, US
Javed Butler
University of Mississippi Medical Center, Jackson, US
Ana Maria Cebrián Cuenca
Murcian Health Service, Murcia, ES
Vijay Chopra
Max Super Speciality Hospital, New Delhi, IN
Kieran Docherty
University of Glasgow, Glasgow, UK
Rodney Falk
Brigham and Women's Hospital, Boston, US
Joao Ferreira
University of Porto, Porto, PT
Gerasimos Filippatos
National and Kapodistrian University of Athens, Athens, GR
Marianna Fontana
University College London, London, UK
Marat Fudim
Duke University, Durham, US
Cristina Gavina
University of Porto, Porto, PT
Camilla Hage
Karolinska University Hospital, Stockholm, SE
Clara Inés Saldarriaga
CardioVID clinic, Medellin, CO
Carsten Israel
Bethel-Clinic, Bielefeld, DE
Ewa Jankowska
Wrocław Medical University, Wrocław, PL
Anu Lala-Trindade
The Mount Sinai Hospital, New York, US
JoAnn Lindenfeld
Vanderbilt University Medical Center, Tennessee, US
Ahmad Masri
Oregon Health & Science University Medical Group, Portland, US
Francesca Musella
Santa Maria delle Grazie Hospital, Naples, IT
Dimitris Papamargaritis
University of Leicester, Leicester, UK
Gianluigi Savarese
Karolinska Institute, Stockholm, SE
Oliver Schnell
University Hospital Erlangen, Erlangen, DE
Pedro Schwartzmann
Hospital Unimed, Ribeirao Preto, BR
David Sim
National Heart Centre Singapore, SG
Scott Solomon
Brigham and Women's Hospital, Boston, US
Cristiana Vitale
St George's University Hospital NHS Foundation Trust, London, UK
Faiez Zannad
University of Lorraine, Vandoeuvre-Les-Nancy, FR